B-cell receptor pathway inhibitors affect CD20 levels and impair antitumor activity of anti-CD20 monoclonal antibodies

Summary

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: K Bojarczuk, M Siernicka, M Dwojak, M Bobrowicz, B Pyrzynska, P Gaj, M Karp, K Giannopoulos, D G Efremov, C Fauriat, J Golab, M Winiarska

Journal title: Leukemia

Journal number: 08876924

Journal publisher: Nature Publishing Group

Published year: 2014

Published pages: 1163-1167

DOI identifier: 10.1038/leu.2014.12

ISSN: 0887-6924